- Home
- EWTX vs GT Comparison
EWTX vs GT Comparison
Compare EWTX & GT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- GT
- Stock Information
- Founded
- EWTX 2017
- GT 1898
- Country
- EWTX United States
- GT United States
- Employees
- EWTX N/A
- GT N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- GT Automotive Aftermarket
- Sector
- EWTX Health Care
- GT Consumer Discretionary
- Exchange
- EWTX Nasdaq
- GT Nasdaq
- Market Cap
- EWTX 2.3B
- GT 2.5B
- IPO Year
- EWTX 2021
- GT N/A
- Fundamental
- Price
- EWTX $20.13
- GT $8.94
- Analyst Decision
- EWTX Buy
- GT Strong Buy
- Analyst Count
- EWTX 8
- GT 3
- Target Price
- EWTX $45.38
- GT $14.30
- AVG Volume (30 Days)
- EWTX 1.5M
- GT 5.1M
- Earning Date
- EWTX 03-03-2025
- GT 05-05-2025
- Dividend Yield
- EWTX N/A
- GT N/A
- EPS Growth
- EWTX N/A
- GT N/A
- EPS
- EWTX N/A
- GT 0.24
- Revenue
- EWTX N/A
- GT $18,878,000,000.00
- Revenue This Year
- EWTX N/A
- GT $0.74
- Revenue Next Year
- EWTX N/A
- GT $1.90
- P/E Ratio
- EWTX N/A
- GT $37.25
- Revenue Growth
- EWTX N/A
- GT N/A
- 52 Week Low
- EWTX $14.90
- GT $7.27
- 52 Week High
- EWTX $38.12
- GT $13.78
- Technical
- Relative Strength Index (RSI)
- EWTX 28.86
- GT 46.26
- Support Level
- EWTX $21.58
- GT $8.65
- Resistance Level
- EWTX $25.36
- GT $9.39
- Average True Range (ATR)
- EWTX 1.99
- GT 0.37
- MACD
- EWTX -0.38
- GT -0.03
- Stochastic Oscillator
- EWTX 2.67
- GT 31.18
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.